Leading the way to safer medication
 Crosscheck  Recommender

Alendronic acid

Also known as: Alendronate sodium

Description

Alendronic acid is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation. The bone formed during treatment with alendronic acid is of normal quality.

ATC Classification

Code
Title
Category
M05BA04
Alendronic acid
M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates

Trade names

Trade name
Countries
ADELAN

Spain

BINOSTO

Cyprus Singapore United Kingdom United States

BONASOL

France Netherlands

DENSATE

Australia

FONAT

Australia

FOSAMAX

Austria Canada France Netherlands Singapore

LEDRONIN

Cyprus

LENDOMAX

Singapore

ONELY

Austria

OSTEONAT

Austria

SEMANDROL

Spain

SOLUDRONATE

Spain

STEOVESS

France

Trade names (in combination): ADROVANCE ALENCALCI D3 BENTEXO BONENDRO FONATPLUS FOSAMAX PLUS FOSAVANCE VANTAVO

Product Monographs

Monograph
Type
Country
FOSAMAX Once Weekly Tablets
MPI, EU: SmPC
UK

2D Molecule Structure

3D Molecule Structure

Unique Ingredient Identifier (UNII)

X1J18R4W8P - ALENDRONIC ACID

CAS Registry Number

121268-17-5 - Alendronate sodium trihydrate

66376-36-1 - alendronic acid

SNOMED-CT

391730008 - Alendronic acid (substance)

 
Next: Usage >